<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="02/06/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9277450" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9277450</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T1" lex="surfactant_protein_A">Surfactant protein A</term> activates <term sem="Protein_complex" id="T2" lex="NF-kappa_B">NF-kappa B</term> in the <term sem="Cell_cultured" id="T3" lex="THP-1_monocytic_cell_line">THP-1 monocytic cell line</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T2" />
<cause idref="T1" />
<clue>Surfactant protein A <clueType>activates</clueType> NF-kappa B <clueLoc>in the THP-1 monocytic cell line</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The expression of <term sem="DNA_domain_or_region" id="T30">many genes</term> for which products are involved in <term sem="Other" id="T4" lex="inflammation">inflammation</term> is controlled by the <term sem="Protein_complex" id="T5" lex="transcriptional_regulator_nuclear_factor_(NF)-kappa_B">transcriptional regulator nuclear factor <term sem="Protein_complex" id="A2">(NF)-kappa B</term></term>.</sentence>
<event id="E2">
<type class="Gene_expression" />
<theme idref="T30" />
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> many genes for which products are involved in inflammation is controlled by the transcriptional regulator nuclear factor (NF)-kappa B.</clue>
<comment>TPS: A1</comment>
</event>
<event id="E3">
<type class="Regulation" />
<theme idref="E2" />
<cause idref="A2" />
<clue>The expression of many genes for which products are involved in inflammation is <clueType>controlled</clueType> <linkCause>by</linkCause> the transcriptional regulator nuclear factor (NF)-kappa B.</clue>
</event>
<sentence id="S3">Because <term sem="Protein_molecule" id="T6" lex="surfactant_protein_(SP)_A">surfactant protein (SP) A</term> is involved in local <term sem="Other" id="A3">host defense</term> in the <term sem="Body_region" id="T7" lex="lung">lung</term> and alters <term sem="Other" id="T8" lex="immune_cell_function">immune cell function</term> by modulating the expression of <term sem="Protein_family_or_group" id="T9" lex="proinflammatory_cytokine">proinflammatory cytokines</term> as well as <term sem="Protein_family_or_group" id="T10" lex="surface_protein">surface proteins</term> involved in <term sem="Other" id="T11" lex="inflammation">inflammation</term>, we hypothesized that <term sem="Protein_molecule" id="T12" lex="SP-A">SP-A</term> exerts its action, at least in part, via activation of <term sem="Protein_complex" id="T13" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E4">
<type class="Regulation" />
<theme idref="A3" />
<cause idref="T6" />
<clue>Because surfactant protein (SP) A is <clueType>involved</clueType> <linkTheme>in</linkTheme> local host defense <clueLoc>in the lung</clueLoc> and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E5">
<type class="Regulation" />
<theme idref="T8" />
<cause idref="E6" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and <clueType>alters</clueType> immune cell function <linkCause>by</linkCause> modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E11">
<type class="Regulation" />
<theme idref="T8" />
<cause idref="E7" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and <clueType>alters</clueType> immune cell function <linkCause>by</linkCause> modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E6">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T6" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by <clueType>modulating</clueType> the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E7">
<type class="Regulation" />
<theme idref="E9" />
<cause idref="T6" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by <clueType>modulating</clueType> the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E8">
<type class="Gene_expression" />
<theme idref="T9" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the <clueType>expression</clueType> <linkTheme>of</linkTheme> proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E9">
<type class="Gene_expression" />
<theme idref="T10" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the <clueType>expression</clueType> <linkTheme>of</linkTheme> proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event id="E10">
<type class="Regulation" />
<theme idref="T11" />
<cause idref="T10" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins <clueType>involved</clueType> <linkTheme>in</linkTheme> inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event uncertainty="doubtful" id="E12">
<type class="Regulation" />
<theme idref="E5" />
<cause idref="E15" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A <clueType>exerts</clueType> <corefTheme>its action</corefTheme>, at least in part, <linkCause>via</linkCause> activation of NF-kappa B.</clue>
</event>
<event uncertainty="doubtful" id="E13">
<type class="Regulation" />
<theme idref="E11" />
<cause idref="E15" />
<clue>Because surfactant protein (SP) A is involved in local host defense <clueLoc>in the lung</clueLoc> and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A <clueType>exerts</clueType> <corefTheme>its action</corefTheme>, at least in part, <linkCause>via</linkCause> activation of NF-kappa B.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T13" />
<cause idref="T12" />
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<sentence id="S4">We used gel shift assays to determine whether <term sem="Protein_molecule" id="T14" lex="SP-A">SP-A</term> activated <term sem="Protein_complex" id="T15" lex="NF-kappa_B">NF-kappa B</term> in the <term sem="Cell_cultured" id="T16" lex="THP-1_cell_line">THP-1 cell line</term>, a <term sem="Cell_cultured" id="T17" lex="human_monocytic_cell_line">human monocytic cell line</term>.</sentence>
<event uncertainty="doubtful" id="E16">
<type class="Positive_regulation" />
<theme idref="T15" />
<cause idref="T14" />
<clue>We used <clueExperiment>gel shift assays</clueExperiment> to determine whether SP-A <clueType>activated</clueType> NF-kappa B <clueLoc>in the THP-1 cell line, a human monocytic cell line</clueLoc>.</clue>
</event>
<sentence id="S5">Activation of <term sem="Protein_complex" id="T18" lex="NF-kappa_B">NF-kappa B</term> in <term sem="Cell_cultured" id="T19" lex="THP-1_cell">THP-1 cells</term> by <term sem="Protein_molecule" id="T20" lex="SP-A">SP-A</term> doses as low as 1 microgram/ml occurred within 30 min of <term sem="Other" id="T21" lex="SP-A_treatment"><term sem="Protein_molecule" id="T22" lex="SP-A">SP-A</term> treatment</term>, peaked at 60 min, and then declined.</sentence>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="T20" />
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueLoc>in THP-1 cells</clueLoc> <linkCause>by</linkCause> SP-A doses as low as 1 microgram/ml occurred <clueTime>within 30 min of SP-A treatment, peaked at 60 min</clueTime>, and then declined.</clue>
</event>
<event assertion="non-exist" id="E18">
<type class="Positive_regulation" />
<theme idref="E17" />
<clue>Activation of NF-kappa B in THP-1 cells by SP-A doses as low as 1 microgram/ml occurred within 30 min of SP-A treatment, peaked at 60 min, and <clueTime>then</clueTime> <clueType>declined</clueType>.</clue>
</event>
<sentence id="S6">This activation is inhibited by known <term sem="Protein_family_or_group" id="A4">inhibitors of <term sem="Protein_complex" id="T23" lex="NF-kappa_B">NF-kappa B</term></term> or by simultaneous treatment of the cells with <term sem="Lipid" id="T24" lex="surfactant_lipid">surfactant lipids</term>.</sentence>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="A4" />
<clue><corefTheme>This activation</corefTheme> is <clueType>inhibited</clueType> <linkCause>by</linkCause> known inhibitors of NF-kappa B or by simultaneous treatment of the cells with surfactant lipids.</clue>
<comment>TPS: A4</comment>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="E21" />
<clue><corefTheme>This activation</corefTheme> is <clueType>inhibited</clueType> by known inhibitors of NF-kappa B or <linkCause>by</linkCause> <clueTime>simultaneous</clueTime> treatment of the cells with surfactant lipids.</clue>
</event>
<event id="E21">
<type class="Artificial_process" />
<theme idref="T19" />
<theme idref="T24" />
<clue>This activation is inhibited by known inhibitors of NF-kappa B or by simultaneous <clueType>treatment</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkTheme>with</linkTheme> surfactant lipids.</clue>
</event>
<sentence id="S7">Moreover, the <term sem="Protein_family_or_group" id="T25" lex="NF-kappa_B_inhibitor"><term sem="Protein_molecule" id="T26" lex="NF-kappa_B"><term sem="Protein_complex" id="T27" lex="NF-kappa_B">NF-kappa B</term></term> inhibitors</term> blocked <term sem="Protein_molecule" id="T29" lex="SP-A">SP-A</term>-dependent <term sem="Other" id="T28">increases</term> in <term sem="RNA_molecule" id="T31" lex="tumor_necrosis_factor-alpha_mRNA">tumor necrosis factor-alpha mRNA</term> levels.</sentence>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="T31" />
<cause idref="T29" />
<clue>Moreover, the NF-kappa B inhibitors blocked SP-A<linkCause>-dependent</linkCause> <clueType>increases</clueType> <linkTheme>in</linkTheme> tumor necrosis factor-alpha mRNA levels.</clue>
</event>
<event id="E23">
<type class="Negative_regulation" />
<theme idref="E22" />
<cause idref="T25" />
<clue>Moreover, the NF-kappa B inhibitors <clueType>blocked</clueType> SP-A-dependent increases in tumor necrosis factor-alpha mRNA levels.</clue>
</event>
<sentence id="S8">These observations suggest a mechanism by which <term sem="Protein_molecule" id="T32" lex="SP-A">SP-A</term> plays a role in the <term sem="Other" id="T39">pathogenesis</term> of some <term sem="Other" id="T33" lex="lung_condition"><term sem="Body_region" id="T34" lex="lung">lung</term> conditions</term> and point to <term sem="Other" id="T35" lex="potential_therapeutic_measure">potential therapeutic measures</term> that could be used to prevent <term sem="Protein_molecule" id="T36" lex="SP-A">SP-A</term> induced <term sem="Other" id="T37" lex="inflammation">inflammation</term> in the <term sem="Body_region" id="T38" lex="lung">lung</term>.</sentence>
<event uncertainty="probable" id="E24">
<type class="Regulation" />
<theme idref="T39" />
<cause idref="T32" />
<clue>These observations suggest a mechanism by which SP-A <clueType>plays a role</clueType> <linkTheme>in</linkTheme> the pathogenesis of some lung conditions and point to potential therapeutic measures that could be used to prevent SP-A induced inflammation in the lung.</clue>
</event>
<event uncertainty="probable" id="E25">
<type class="Negative_regulation" />
<theme idref="E26" />
<clue>These observations suggest a mechanism by which SP-A plays a role in the pathogenesis of some lung conditions and point to potential therapeutic measures that could be used to <clueType>prevent</clueType> SP-A induced inflammation in the lung.</clue>
</event>
<event uncertainty="probable" id="E26">
<type class="Positive_regulation" />
<theme idref="T37" />
<cause idref="T36" />
<clue>These observations suggest a mechanism by which SP-A plays a role in the pathogenesis of some lung conditions and point to potential therapeutic measures that could be used to prevent SP-A <clueType>induced</clueType> inflammation <clueLoc>in the lung</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
